Timing of Antiretroviral Therapy for HIV-1 Infection and Tuberculosis

V. Havlir, Diane; A. Kendall, Michelle; Ive, Prudence; Kumwenda, Johnstone; Swindells, Susan; S. Qasba, Sarojini; F. Luetkemeyer, Anne; Hogg, Evelyn; F. Rooney, James; Wu, Xingye; C. Hosseinipour, Mina; Lalloo, Umesh; G. Veloso, Valdiléa; Some, Fatuma; Kumarasamy, N.; Padayatchi, Nesri; Santos, Breno; E. Reid, Stewart; Hakim, James; Mohapi, Lerato; Mugyenyi, Peter; Sánchez, Jorge; R. Lama, Javier; W. Pape, Jean; Sanchez, Alejandro; Asmelash, Aida; Moko, E.; Sawe, Fred; Andersen, Janet; Sanne, Ian

doi:10.1056/nejmoa1013607

Public

Timing of Antiretroviral Therapy for HIV-1 Infection and Tuberculosis

Published in New England Journal of Medicine • Oct 19, 2011

Authors:

Diane V. Havlir

Michelle A. Kendall

Prudence Ive

Abstract

BACKGROUND: Antiretroviral therapy (ART) is indicated during tuberculosis treatment in patients infected with human immunodeficiency virus type 1 (HIV-1), but the timing for the initiation of ART when tuberculosis is diagnosed in patients with various levels of immune compromise is not known. METHOD...

Subject

Medicine

Tuberculosis

Antiretroviral therapy

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!